BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21523732)

  • 1. Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival.
    Wilgus ML; Borczuk AC; Stoopler M; Ginsburg M; Gorenstein L; Sonett JR; Powell CA
    Cancer; 2011 May; 117(10):2186-91. PubMed ID: 21523732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.
    Wei L; Song XR; Sun JJ; Wang XW; Xie L; Lv LY
    Cancer Biother Radiopharm; 2012 Dec; 27(10):672-7. PubMed ID: 23140307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
    Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K
    Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling.
    Gao Y; Xiao Q; Ma H; Li L; Liu J; Feng Y; Fang Z; Wu J; Han X; Zhang J; Sun Y; Wu G; Padera R; Chen H; Wong KK; Ge G; Ji H
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18892-7. PubMed ID: 20956321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of Ki-67, p53, transforming growth factor-β and lysyl oxidase in the metastasis of lung cancer.
    Araz O; Demirci E; Ucar EY; Calik M; Karaman A; Durur-Subasi I; Orsal E; Subasi M; Daloglu F; Akgun M
    Respirology; 2014 Oct; 19(7):1034-9. PubMed ID: 24995672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.
    Kubouchi Y; Yurugi Y; Wakahara M; Sakabe T; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
    Histopathology; 2018 Feb; 72(3):490-499. PubMed ID: 28881047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.
    Zhu J; Huang S; Wu G; Huang C; Li X; Chen Z; Zhao L; Zhao Y
    Dig Dis Sci; 2015 Oct; 60(10):3019-31. PubMed ID: 26048020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LOX expression in primary nasopharyngeal carcinoma: correlation with prognostic parameters and outcome.
    Hua YJ; Wang HY; Tang LQ; Chen QY; Shao JY; Mai HQ
    Oncotarget; 2016 Feb; 7(7):8200-7. PubMed ID: 26882568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
    Le QT; Harris J; Magliocco AM; Kong CS; Diaz R; Shin B; Cao H; Trotti A; Erler JT; Chung CH; Dicker A; Pajak TF; Giaccia AJ; Ang KK
    J Clin Oncol; 2009 Sep; 27(26):4281-6. PubMed ID: 19667273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.
    Wu Y; Huang B; Liu Q; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
    Xu XY; Lin N; Li YM; Zhi C; Shen H
    Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of tumor PD-L1 expression with EGFR wild-type status and poor prognosis in lung adenocarcinoma.
    Inamura K; Yokouchi Y; Sakakibara R; Kobayashi M; Subat S; Ninomiya H; Nagano H; Nomura K; Okumura S; Ishikawa Y
    Jpn J Clin Oncol; 2016 Oct; 46(10):935-941. PubMed ID: 27511990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forkhead box C1 promotes metastasis and invasion of non-small cell lung cancer by binding directly to the lysyl oxidase promoter.
    Gong R; Lin W; Gao A; Liu Y; Li J; Sun M; Chen X; Han S; Men C; Sun Y; Liu J
    Cancer Sci; 2019 Dec; 110(12):3663-3676. PubMed ID: 31597217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma.
    Qixing M; Juqing X; Yajing W; Gaochao D; Wenjie X; Run S; Anpeng W; Lin X; Feng J; Jun W
    Tumour Biol; 2017 Apr; 39(4):1010428317698340. PubMed ID: 28381170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases.
    Fujimoto M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Hirata M; Momose M; Date H; Haga H
    Histopathology; 2017 Jan; 70(2):232-241. PubMed ID: 27467545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma.
    Bueno R; Hughes E; Wagner S; Gutin AS; Lanchbury JS; Zheng Y; Archer MA; Gustafson C; Jones JT; Rushton K; Saam J; Kim E; Barberis M; Wistuba I; Wenstrup RJ; Wallace WA; Hartman AR; Harrison DJ
    J Thorac Oncol; 2015 Jan; 10(1):67-73. PubMed ID: 25396679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.